G

Genfit SA
D

GNFT

4.25000
USD
-0.11
(-2.52%)
Market Closed
Volume
157
EPS
1
Div Yield
-
P/E
11
Market Cap
212,102,553
Related Instruments
    A
    ALVR
    0.02740
    (4.88%)
    0.58900 USD
    C
    CYRX
    -0.40500
    (-5.48%)
    6.99000 USD
    D
    DMTK
    0
    (0%)
    0.000000 USD
    O
    OPRT
    0.04000
    (1.31%)
    3.10000 USD
    P
    PRFX
    -0.01990
    (-3.75%)
    0.51010 USD
    More
News

Title: Genfit SA

Sector: Healthcare
Industry: Biotechnology
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.